BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31814524)

  • 1. 4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation.
    Shi X; Gong L; Liu Y; Hou K; Fan Y; Li C; Wen T; Qu X; Che X
    Epigenetics; 2020; 15(6-7):632-645. PubMed ID: 31814524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation.
    Shi X; Zheng C; Li C; Hou K; Wang X; Yang Z; Liu C; Liu Y; Che X; Qu X
    Cell Biol Int; 2018 Jan; 42(1):53-62. PubMed ID: 28851073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions.
    Tsai CH; Li CH; Liao PL; Chang YW; Cheng YW; Kang JJ
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118564. PubMed ID: 31672612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
    Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
    Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.
    Wu SM; Jan YJ; Tsai SC; Pan HC; Shen CC; Yang CN; Lee SH; Liu SH; Shen LW; Chiu CS; Arbiser JL; Meng M; Sheu ML
    Cell Biol Toxicol; 2023 Oct; 39(5):1873-1896. PubMed ID: 34973135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
    Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
    Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylases Promote ER Stress Induced Epithelial Mesenchymal Transition in Human Lung Epithelial Cells.
    Liu D; Zhu H; Gong L; Pu S; Wu Y; Zhang W; Huang G
    Cell Physiol Biochem; 2018; 46(5):1821-1834. PubMed ID: 29705800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor.
    Mimori S; Ohtaka H; Koshikawa Y; Kawada K; Kaneko M; Okuma Y; Nomura Y; Murakami Y; Hamana H
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6015-8. PubMed ID: 24044874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid.
    Almotairy ARZ; Gandin V; Morrison L; Marzano C; Montagner D; Erxleben A
    J Inorg Biochem; 2017 Dec; 177():1-7. PubMed ID: 28918353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells.
    Gatla HR; Zou Y; Uddin MM; Singha B; Bu P; Vancura A; Vancurova I
    J Biol Chem; 2017 Mar; 292(12):5043-5054. PubMed ID: 28167529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.
    Kiweler N; Brill B; Wirth M; Breuksch I; Laguna T; Dietrich C; Strand S; Schneider G; Groner B; Butter F; Heinzel T; Brenner W; Krämer OH
    Arch Toxicol; 2018 Jul; 92(7):2227-2243. PubMed ID: 29845424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer.
    Amnekar RV; Khan SA; Rashid M; Khade B; Thorat R; Gera P; Shrikhande SV; Smoot DT; Ashktorab H; Gupta S
    World J Gastroenterol; 2020 Feb; 26(6):598-613. PubMed ID: 32103870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A augments esophageal squamous cell carcinoma cells migration by inducing acetylation of RelA at K310 leading epithelia-mesenchymal transition.
    Huang K; Liu Y; Gu C; Liu D; Zhao B
    Anticancer Drugs; 2020 Jul; 31(6):567-574. PubMed ID: 32282366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L; Chang Y; Cao P
    Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.
    Kusaczuk M; Krętowski R; Bartoszewicz M; Cechowska-Pasko M
    Tumour Biol; 2016 Jan; 37(1):931-42. PubMed ID: 26260271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression.
    Schmeck B; Lorenz J; N'guessan PD; Opitz B; van Laak V; Zahlten J; Slevogt H; Witzenrath M; Flieger A; Suttorp N; Hippenstiel S
    J Immunol; 2008 Jul; 181(2):940-7. PubMed ID: 18606645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A induces mesenchymal-like morphological change and gene expression but inhibits migration and colony formation in human cancer cells.
    Han RF; Li K; Yang ZS; Chen ZG; Yang WC
    Mol Med Rep; 2014 Dec; 10(6):3211-6. PubMed ID: 25269990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.